174 related articles for article (PubMed ID: 26371192)
1. Febrile Seizures After 2010-2011 Trivalent Inactivated Influenza Vaccine.
Kawai AT; Martin D; Kulldorff M; Li L; Cole DV; McMahill-Walraven CN; Selvam N; Selvan MS; Lee GM
Pediatrics; 2015 Oct; 136(4):e848-55. PubMed ID: 26371192
[TBL] [Abstract][Full Text] [Related]
2. Signal identification and evaluation for risk of febrile seizures in children following trivalent inactivated influenza vaccine in the Vaccine Safety Datalink Project, 2010-2011.
Tse A; Tseng HF; Greene SK; Vellozzi C; Lee GM;
Vaccine; 2012 Mar; 30(11):2024-31. PubMed ID: 22361304
[TBL] [Abstract][Full Text] [Related]
3. Risk of febrile seizures and epilepsy after vaccination with diphtheria, tetanus, acellular pertussis, inactivated poliovirus, and Haemophilus influenzae type B.
Sun Y; Christensen J; Hviid A; Li J; Vedsted P; Olsen J; Vestergaard M
JAMA; 2012 Feb; 307(8):823-31. PubMed ID: 22357833
[TBL] [Abstract][Full Text] [Related]
4. The risk of febrile seizures following influenza and 13-valent pneumococcal conjugate vaccines.
Baker MA; Jankosky C; Yih WK; Gruber S; Li L; Cocoros NM; Lipowicz H; Coronel-Moreno C; DeLuccia S; Lin ND; McMahill-Walraven CN; Menschik D; Selvan MS; Selvam N; Chen Tilney R; Zichittella L; Lee GM; Kawai AT
Vaccine; 2020 Feb; 38(9):2166-2171. PubMed ID: 32019703
[TBL] [Abstract][Full Text] [Related]
5. Febrile Seizure Risk After Vaccination in Children 6 to 23 Months.
Duffy J; Weintraub E; Hambidge SJ; Jackson LA; Kharbanda EO; Klein NP; Lee GM; Marcy SM; Nakasato CC; Naleway A; Omer SB; Vellozzi C; DeStefano F;
Pediatrics; 2016 Jul; 138(1):. PubMed ID: 27273711
[TBL] [Abstract][Full Text] [Related]
6. Risk of fever after pediatric trivalent inactivated influenza vaccine and 13-valent pneumococcal conjugate vaccine.
Stockwell MS; Broder K; LaRussa P; Lewis P; Fernandez N; Sharma D; Barrett A; Sosa J; Vellozzi C
JAMA Pediatr; 2014 Mar; 168(3):211-9. PubMed ID: 24395025
[TBL] [Abstract][Full Text] [Related]
7. 13-valent pneumococcal conjugate vaccine given with meningococcal C-tetanus toxoid conjugate and other routine pediatric vaccinations: immunogenicity and safety.
Martinón-Torres F; Gimenez-Sanchez F; Gurtman A; Bernaola E; Diez-Domingo J; Carmona A; Sidhu M; Sarkozy DA; Gruber WC; Emini EA; Scott DA;
Pediatr Infect Dis J; 2012 Apr; 31(4):392-9. PubMed ID: 22301472
[TBL] [Abstract][Full Text] [Related]
8. Fever After Influenza, Diphtheria-Tetanus-Acellular Pertussis, and Pneumococcal Vaccinations.
Walter EB; Klein NP; Wodi AP; Rountree W; Todd CA; Wiesner A; Duffy J; Marquez PL; Broder KR
Pediatrics; 2020 Mar; 145(3):. PubMed ID: 32029684
[TBL] [Abstract][Full Text] [Related]
9. Safety and immunogenicity of a 13-valent pneumococcal conjugate vaccine in healthy infants and toddlers given with routine pediatric vaccinations in Canada.
Vanderkooi OG; Scheifele DW; Girgenti D; Halperin SA; Patterson SD; Gruber WC; Emini EA; Scott DA; Kellner JD;
Pediatr Infect Dis J; 2012 Jan; 31(1):72-7. PubMed ID: 21960186
[TBL] [Abstract][Full Text] [Related]
10. A randomized, double-blind trial to evaluate immunogenicity and safety of 13-valent pneumococcal conjugate vaccine given concomitantly with trivalent influenza vaccine in adults aged ≥65 years.
Schwarz TF; Flamaing J; Rümke HC; Penzes J; Juergens C; Wenz A; Jayawardene D; Giardina P; Emini EA; Gruber WC; Schmoele-Thoma B
Vaccine; 2011 Jul; 29(32):5195-202. PubMed ID: 21619909
[TBL] [Abstract][Full Text] [Related]
11. Assessment of functional antibacterial opsonophagocytic antibodies elicited by 13-valent pneumococcal conjugate vaccine administered concomitantly with trivalent influenza vaccine in a randomized clinical trial in adults aged ≥65 years.
Schwarz TF; Schmoele-Thoma B
Vaccine; 2013 Jan; 31(2):291-4. PubMed ID: 23123107
[TBL] [Abstract][Full Text] [Related]
12. Prophylactic antipyretics for prevention of febrile seizures following vaccination.
Monfries N; Goldman RD
Can Fam Physician; 2017 Feb; 63(2):128-130. PubMed ID: 28209678
[No Abstract] [Full Text] [Related]
13. Postlicensure surveillance for pre-specified adverse events following the 13-valent pneumococcal conjugate vaccine in children.
Tseng HF; Sy LS; Liu IL; Qian L; Marcy SM; Weintraub E; Yih K; Baxter R; Glanz JM; Donahue J; Naleway A; Nordin J; Jacobsen SJ
Vaccine; 2013 May; 31(22):2578-83. PubMed ID: 23579258
[TBL] [Abstract][Full Text] [Related]
14. Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998-2001.
Bisgard KM; Rhodes P; Connelly BL; Bi D; Hahn C; Patrick S; Glodé MP; Ehresmann KR;
Pediatrics; 2005 Aug; 116(2):e285-94. PubMed ID: 16061582
[TBL] [Abstract][Full Text] [Related]
15. Immunogenicity of a combination vaccine containing diphtheria toxoid, tetanus toxoid, three-component acellular pertussis, hepatitis B, inactivated polio virus, and Haemophilus influenzae type b when given concomitantly with 13-valent pneumococcal conjugate vaccine.
Gimenez-Sanchez F; Kieninger DM; Kueper K; Martinon-Torres F; Bernaola E; Diez-Domingo J; Steul K; Juergens C; Gurtman A; Giardina P; Liang JZ; Gruber WC; Emini EA; Scott DA;
Vaccine; 2011 Aug; 29(35):6042-8. PubMed ID: 21704105
[TBL] [Abstract][Full Text] [Related]
16. Immunological effect of administration of sequential doses of Haemophilus influenzae type b and pneumococcal conjugate vaccines in the same versus alternating limbs in the routine infant immunisation schedule: an open-label randomised controlled trial.
Iro MA; Khatami A; Marshall AS; Pace D; Voysey M; McKenna J; Campbell D; Attard-Montalto S; Finn A; White C; Faust SN; Kent A; Heath PT; MacLeod E; Stanford E; Findlow H; Almond R; Bai X; Borrow R; Snape MD; Pollard AJ
Lancet Infect Dis; 2015 Feb; 15(2):172-80. PubMed ID: 25577661
[TBL] [Abstract][Full Text] [Related]
17. Post licensure surveillance of influenza vaccines in the Vaccine Safety Datalink in the 2013-2014 and 2014-2015 seasons.
Li R; Stewart B; McNeil MM; Duffy J; Nelson J; Kawai AT; Baxter R; Belongia EA; Weintraub E
Pharmacoepidemiol Drug Saf; 2016 Aug; 25(8):928-34. PubMed ID: 27037540
[TBL] [Abstract][Full Text] [Related]
18. Vaccines and febrile seizures.
Principi N; Esposito S
Expert Rev Vaccines; 2013 Aug; 12(8):885-92. PubMed ID: 23984960
[TBL] [Abstract][Full Text] [Related]
19. Immunogenicity and safety of a combination diphtheria, tetanus toxoid, acellular pertussis, hepatitis B, and inactivated poliovirus vaccine coadministered with a 7-valent pneumococcal conjugate vaccine and a Haemophilus influenzae type b conjugate vaccine.
Pichichero ME; Bernstein H; Blatter MM; Schuerman L; Cheuvart B; Holmes SJ;
J Pediatr; 2007 Jul; 151(1):43-9, 49.e1-2. PubMed ID: 17586189
[TBL] [Abstract][Full Text] [Related]
20. Safety of diphtheria, tetanus, acellular pertussis and inactivated poliovirus (DTaP-IPV) vaccine.
Daley MF; Yih WK; Glanz JM; Hambidge SJ; Narwaney KJ; Yin R; Li L; Nelson JC; Nordin JD; Klein NP; Jacobsen SJ; Weintraub E
Vaccine; 2014 May; 32(25):3019-24. PubMed ID: 24699471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
